===== phenotype 28=================================================================
proportion of pts: 0.164220547402
lambda: 17350.2478517
----------------------------------------
Disorders of lipoid metabolism	0.142
Hypertensive disease	0.132
Ischemic heart disease	0.116
Arthropathies and related disorders	0.087
Disorders of the eye and adnexa	0.082
Symptoms involving respiratory system and other chest symptoms	0.082
Diabetes	0.080
Other diseases of skin and subcutaneous tissue	0.080
Dorsopathies	0.070
Range name na	0.067
Malignant neoplasm of skin	0.062
----------------------------------------
Vasodilator Agents	0.074
Platelet Aggregation Inhibitors	0.069
Fibrinolytic Agents	0.069
Anti-Ulcer Agents	0.068
Antipyretics	0.068
Anticholesteremic Agents	0.067
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.067
Antihypertensive Agents	0.067
Proton Pump Inhibitors	0.066
Anti-Inflammatory Agents, Non-Steroidal	0.066
Anti-Arrhythmia Agents	0.065
Cyclooxygenase Inhibitors	0.064
Sympatholytics	0.064
Adrenergic beta-1 Receptor Antagonists	0.063
Vitamins	0.062
===== phenotype 9=================================================================
proportion of pts: 0.144387147957
lambda: 15159.558157
----------------------------------------
Ischemic heart disease	0.142
Hypertensive disease	0.106
Symptoms involving respiratory system and other chest symptoms	0.104
Other forms of heart disease	0.099
Disorders of lipoid metabolism	0.097
Range name na	0.084
Other diseases of respiratory system	0.080
Miscellaneous diagnostic and therapeutic procedures	0.080
General symptoms	0.078
Symptoms involving skin and other integumentary tissue	0.065
Operations on the cardiovascular system	0.064
----------------------------------------
Analgesics, Non-Narcotic	0.098
Sympatholytics	0.087
Explosive Agents	0.083
Purinergic P2Y Receptor Antagonists	0.080
Cyclooxygenase Inhibitors	0.079
Adrenergic beta-1 Receptor Antagonists	0.079
Vasodilator Agents	0.078
Platelet Aggregation Inhibitors	0.077
Fibrinolytic Agents	0.073
Anti-Arrhythmia Agents	0.070
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.068
Anticholesteremic Agents	0.064
Anti-Inflammatory Agents, Non-Steroidal	0.062
===== phenotype 42=================================================================
proportion of pts: 0.181277270924
lambda: 14587.4610411
----------------------------------------
Diabetes	0.177
Disorders of lipoid metabolism	0.171
Hypertensive disease	0.165
Arthropathies and related disorders	0.129
Disorders of the eye and adnexa	0.096
Rheumatism, excluding the back	0.089
Organic sleep disorders	0.087
Dorsopathies	0.086
----------------------------------------
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.098
Anticholesteremic Agents	0.093
Cyclooxygenase Inhibitors	0.091
Anti-Inflammatory Agents, Non-Steroidal	0.091
Antipyretics	0.089
Hypoglycemic Agents	0.086
Antihypertensive Agents	0.082
Fibrinolytic Agents	0.082
Platelet Aggregation Inhibitors	0.081
Angiotensin-Converting Enzyme Inhibitors	0.078
Hypolipidemic Agents	0.065
Cardiotonic Agents	0.064
===== phenotype 33=================================================================
proportion of pts: 0.170963903213
lambda: 14563.2510589
----------------------------------------
Arthropathies and related disorders	0.121
Hypertensive disease	0.120
Rheumatism, excluding the back	0.109
Diseases of esophagus, stomach, and duodenum	0.101
Dorsopathies	0.094
Range name na	0.082
Symptoms involving skin and other integumentary tissue	0.080
Symptoms involving respiratory system and other chest symptoms	0.076
General symptoms	0.076
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.073
Acute respiratory infections	0.068
----------------------------------------
Proton Pump Inhibitors	0.096
Cyclooxygenase Inhibitors	0.096
Anti-Ulcer Agents	0.094
Anti-Inflammatory Agents, Non-Steroidal	0.093
Antipyretics	0.090
Platelet Aggregation Inhibitors	0.086
Vitamins	0.083
Fibrinolytic Agents	0.083
Anti-Bacterial Agents	0.075
Sodium Chloride Symporter Inhibitors	0.070
Bone Density Conservation Agents	0.067
Antihypertensive Agents	0.067
===== phenotype 25=================================================================
proportion of pts: 0.155890519635
lambda: 14359.1628947
----------------------------------------
Disorders of lipoid metabolism	0.119
Hypertensive disease	0.116
Range name na	0.109
Cerebrovascular disease	0.104
Arthropathies and related disorders	0.089
General symptoms	0.086
Symptoms involving respiratory system and other chest symptoms	0.084
Other forms of heart disease	0.080
Rheumatism, excluding the back	0.079
Nutritional deficiencies	0.070
Diseases of the ear and mastoid process	0.064
----------------------------------------
Vitamins	0.090
Antipyretics	0.080
Platelet Aggregation Inhibitors	0.079
Fibrinolytic Agents	0.078
Cyclooxygenase Inhibitors	0.072
Anti-Inflammatory Agents, Non-Steroidal	0.072
Sodium Chloride Symporter Inhibitors	0.069
Anticholesteremic Agents	0.068
Bone Density Conservation Agents	0.068
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.067
Diuretics	0.065
Antihypertensive Agents	0.064
Hypolipidemic Agents	0.064
Antioxidants	0.063
===== phenotype 19=================================================================
proportion of pts: 0.152717175724
lambda: 14162.374875
----------------------------------------
Diabetes	0.142
Hypertensive disease	0.101
Disorders of the eye and adnexa	0.096
Mycoses	0.096
Range name na	0.095
Disorders of lipoid metabolism	0.095
Other diseases of skin and subcutaneous tissue	0.094
General symptoms	0.082
Symptoms involving respiratory system and other chest symptoms	0.071
Infections of skin and subcutaneous tissue	0.064
Acute respiratory infections	0.063
----------------------------------------
Hypoglycemic Agents	0.092
Angiotensin-Converting Enzyme Inhibitors	0.079
Anti-Bacterial Agents	0.077
Anticholesteremic Agents	0.074
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.071
Antipyretics	0.071
Hypolipidemic Agents	0.071
Cardiotonic Agents	0.070
Antihypertensive Agents	0.067
Fibrinolytic Agents	0.067
Anti-Inflammatory Agents, Non-Steroidal	0.066
Platelet Aggregation Inhibitors	0.066
Cyclooxygenase Inhibitors	0.065
Anti-Allergic Agents	0.064
===== phenotype 2=================================================================
proportion of pts: 0.16501388338
lambda: 13787.6656533
----------------------------------------
Ischemic heart disease	0.155
Disorders of lipoid metabolism	0.125
Hypertensive disease	0.123
Symptoms involving respiratory system and other chest symptoms	0.097
Chronic obstructive pulmonary disease and allied conditions	0.082
Other forms of heart disease	0.078
Range name na	0.076
Diseases of esophagus, stomach, and duodenum	0.069
Anemias	0.067
Drug dependence	0.064
Benign neoplasm of other parts of digestive system	0.064
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.089
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.087
Anticholesteremic Agents	0.083
Hypnotics and Sedatives	0.082
Antipyretics	0.080
Platelet Aggregation Inhibitors	0.080
Fibrinolytic Agents	0.079
Cardiotonic Agents	0.079
Hypolipidemic Agents	0.074
Cyclooxygenase Inhibitors	0.069
Anti-Inflammatory Agents, Non-Steroidal	0.068
Antihypertensive Agents	0.068
Vasodilator Agents	0.062
===== phenotype 0=================================================================
proportion of pts: 0.150337167791
lambda: 13336.5525536
----------------------------------------
Disorders of lipoid metabolism	0.127
Hypertensive disease	0.126
Range name na	0.096
Other forms of heart disease	0.091
Diabetes	0.088
Ischemic heart disease	0.087
Symptoms involving respiratory system and other chest symptoms	0.080
Arthropathies and related disorders	0.080
Symptoms involving skin and other integumentary tissue	0.080
Disorders of the peripheral nervous system	0.075
Symptoms involving urinary system	0.071
----------------------------------------
Anti-Anxiety Agents	0.099
Anticonvulsants	0.096
Excitatory Amino Acid Antagonists	0.095
Antiparkinson Agents	0.094
Calcium Channel Blockers	0.087
Proton Pump Inhibitors	0.085
Analgesics	0.082
Anti-Ulcer Agents	0.080
Antimanic Agents	0.079
Sodium Potassium Chloride Symporter Inhibitors	0.072
Diuretics	0.067
Antioxidants	0.065
===== phenotype 35=================================================================
proportion of pts: 0.165410551369
lambda: 13275.4814607
----------------------------------------
Symptoms involving skin and other integumentary tissue	0.129
Hypertensive disease	0.108
Arthropathies and related disorders	0.108
Diseases of the ear and mastoid process	0.090
Other diseases of the upper respiratory tract	0.082
Rheumatism, excluding the back	0.074
Acute respiratory infections	0.073
Diseases of veins and lymphatics, and other diseases of circulatory system	0.073
Disorders of thyroid gland	0.072
Other forms of heart disease	0.065
Other diseases of skin and subcutaneous tissue	0.063
Anemias	0.063
----------------------------------------
Vasodilator Agents	0.089
Calcium Channel Blockers	0.087
Diuretics	0.080
Antipyretics	0.080
Antihypertensive Agents	0.079
Cyclooxygenase Inhibitors	0.077
Anti-Inflammatory Agents, Non-Steroidal	0.077
Fibrinolytic Agents	0.077
Platelet Aggregation Inhibitors	0.076
Anti-Allergic Agents	0.070
Anti-Arrhythmia Agents	0.070
Sodium Potassium Chloride Symporter Inhibitors	0.070
Anti-Inflammatory Agents	0.068
===== phenotype 1=================================================================
proportion of pts: 0.159460531535
lambda: 12779.2627502
----------------------------------------
Disorders of thyroid gland	0.118
Symptoms involving head and neck	0.108
Disorders of the eye and adnexa	0.105
Disorders of lipoid metabolism	0.105
Symptoms involving digestive system	0.102
General symptoms	0.101
Nutritional deficiencies	0.099
Other symptoms involving abdomen and pelvis	0.095
Diseases of esophagus, stomach, and duodenum	0.089
Other diseases of intestines and peritoneum	0.079
----------------------------------------
Antihypertensive Agents	0.078
Proton Pump Inhibitors	0.074
Anti-Ulcer Agents	0.074
Calcium Channel Blockers	0.072
Diuretics	0.068
Vasodilator Agents	0.067
Anti-Arrhythmia Agents	0.067
Hypnotics and Sedatives	0.067
Anticholesteremic Agents	0.065
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.064
Anti-Allergic Agents	0.062
Anti-Inflammatory Agents, Non-Steroidal	0.062
Anti-Anxiety Agents	0.060
Cyclooxygenase Inhibitors	0.060
Serotonin Uptake Inhibitors	0.060
===== phenotype 26=================================================================
proportion of pts: 0.15787385958
lambda: 11812.2300103
----------------------------------------
Hypertensive disease	0.128
Range name na	0.127
Arthropathies and related disorders	0.106
Dorsopathies	0.102
Symptoms involving urinary system	0.096
Other diseases of urinary system	0.094
Rheumatism, excluding the back	0.094
General symptoms	0.088
Disorders of lipoid metabolism	0.086
Other disorders of female genital tract	0.079
----------------------------------------
Analgesics, Non-Narcotic	0.105
Angiotensin-Converting Enzyme Inhibitors	0.099
Cardiotonic Agents	0.092
Surface-Active Agents	0.091
Cyclooxygenase Inhibitors	0.077
Anti-Inflammatory Agents, Non-Steroidal	0.076
Calcium Channel Blockers	0.074
Antipyretics	0.068
Solvents	0.068
Antihypertensive Agents	0.065
Estrogens	0.063
Bone Density Conservation Agents	0.063
Drug Carriers	0.061
===== phenotype 40=================================================================
proportion of pts: 0.152320507735
lambda: 11797.9631197
----------------------------------------
Disorders of lipoid metabolism	0.139
Hypertensive disease	0.137
Range name na	0.133
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.122
General symptoms	0.110
Disorders of the eye and adnexa	0.103
Other diseases of urinary system	0.095
Symptoms involving urinary system	0.092
Ischemic heart disease	0.069
----------------------------------------
Vitamins	0.089
Antihypertensive Agents	0.075
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.074
Platelet Aggregation Inhibitors	0.074
Anticholesteremic Agents	0.074
Anti-Arrhythmia Agents	0.074
Fibrinolytic Agents	0.073
Antipyretics	0.071
Anti-Inflammatory Agents, Non-Steroidal	0.069
Vasodilator Agents	0.069
Cyclooxygenase Inhibitors	0.068
Sympatholytics	0.065
Bone Density Conservation Agents	0.063
Adrenergic beta-1 Receptor Antagonists	0.062
===== phenotype 13=================================================================
proportion of pts: 0.174930583102
lambda: 11456.4436119
----------------------------------------
Hypertensive disease	0.166
Disorders of lipoid metabolism	0.145
Other diseases of the upper respiratory tract	0.128
Acute respiratory infections	0.118
Range name na	0.103
Disorders of thyroid gland	0.090
General symptoms	0.086
Diseases of the ear and mastoid process	0.084
Symptoms involving respiratory system and other chest symptoms	0.080
----------------------------------------
Anti-Allergic Agents	0.113
Anti-Inflammatory Agents	0.108
Bronchodilator Agents	0.107
Histamine H1 Antagonists, Non-Sedating	0.105
Dermatologic Agents	0.103
Antihypertensive Agents	0.089
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.081
Anticholesteremic Agents	0.078
Anti-Bacterial Agents	0.076
Anti-Inflammatory Agents, Non-Steroidal	0.072
Cyclooxygenase Inhibitors	0.069
===== phenotype 32=================================================================
proportion of pts: 0.167790559302
lambda: 11414.2656174
----------------------------------------
Hypertensive disease	0.139
Rheumatism, excluding the back	0.132
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.131
Arthropathies and related disorders	0.123
Disorders of lipoid metabolism	0.121
Disorders of thyroid gland	0.121
Symptoms involving respiratory system and other chest symptoms	0.084
Dorsopathies	0.079
Other diseases of skin and subcutaneous tissue	0.070
----------------------------------------
Vitamins	0.088
Angiotensin-Converting Enzyme Inhibitors	0.083
Bone Density Conservation Agents	0.082
Vasodilator Agents	0.080
Antihypertensive Agents	0.074
Hypnotics and Sedatives	0.073
Calcium Channel Blockers	0.070
Cardiotonic Agents	0.067
Antidepressive Agents, Second-Generation	0.066
Cyclooxygenase Inhibitors	0.065
Anti-Inflammatory Agents, Non-Steroidal	0.064
Serotonin Uptake Inhibitors	0.064
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.063
Antipyretics	0.061
===== phenotype 14=================================================================
proportion of pts: 0.144783815946
lambda: 11386.8481971
----------------------------------------
Diseases of veins and lymphatics, and other diseases of circulatory system	0.105
Other diseases of urinary system	0.103
Nonspecific findings on examination of blood	0.101
Diseases of male genital organs	0.094
Dorsopathies	0.084
Symptoms involving digestive system	0.083
Other diseases of intestines and peritoneum	0.077
Disorders of lipoid metabolism	0.077
Symptoms involving urinary system	0.074
Anemias	0.069
Ischemic heart disease	0.068
Malignant neoplasm of male and female genital organs	0.064
----------------------------------------
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.092
Anticholesteremic Agents	0.088
Platelet Aggregation Inhibitors	0.084
Vasodilator Agents	0.081
Fibrinolytic Agents	0.078
Hypolipidemic Agents	0.078
Antihypertensive Agents	0.076
Antipyretics	0.075
Cyclooxygenase Inhibitors	0.075
Sympatholytics	0.073
Anti-Inflammatory Agents, Non-Steroidal	0.072
Anti-Arrhythmia Agents	0.068
Adrenergic alpha-1 Receptor Antagonists	0.061
===== phenotype 41=================================================================
proportion of pts: 0.155097183657
lambda: 11278.6298062
----------------------------------------
Hypertensive disease	0.144
Disorders of lipoid metabolism	0.140
Diabetes	0.122
Rheumatism, excluding the back	0.105
Arthropathies and related disorders	0.099
Range name na	0.090
Symptoms involving respiratory system and other chest symptoms	0.087
Anemias	0.073
Other forms of heart disease	0.072
Symptoms involving cardiovascular system	0.069
----------------------------------------
Sympatholytics	0.123
Adrenergic beta-1 Receptor Antagonists	0.118
Anti-Arrhythmia Agents	0.111
Sodium Chloride Symporter Inhibitors	0.090
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.089
Anticholesteremic Agents	0.089
Hypoglycemic Agents	0.085
Diuretics	0.079
Vitamin B Complex	0.076
Hypolipidemic Agents	0.071
Antihypertensive Agents	0.069
===== phenotype 15=================================================================
proportion of pts: 0.159460531535
lambda: 11150.8106795
----------------------------------------
Hypertensive disease	0.139
Symptoms involving respiratory system and other chest symptoms	0.125
Other symptoms involving abdomen and pelvis	0.107
Symptoms involving cardiovascular system	0.106
Diseases of male genital organs	0.103
Disorders of lipoid metabolism	0.097
Other forms of heart disease	0.085
Range name na	0.081
Other diseases of urinary system	0.080
Other diseases of intestines and peritoneum	0.076
----------------------------------------
Antihypertensive Agents	0.096
Antipyretics	0.095
Anti-Inflammatory Agents, Non-Steroidal	0.093
Cyclooxygenase Inhibitors	0.091
Vasodilator Agents	0.089
Angiotensin-Converting Enzyme Inhibitors	0.086
Fibrinolytic Agents	0.083
Platelet Aggregation Inhibitors	0.082
Calcium Channel Blockers	0.078
Cardiotonic Agents	0.075
Diuretics	0.070
Anti-Arrhythmia Agents	0.061
===== phenotype 24=================================================================
proportion of pts: 0.146370487902
lambda: 11065.522527
----------------------------------------
Hypertensive disease	0.140
Range name na	0.115
Arthropathies and related disorders	0.106
Rheumatism, excluding the back	0.101
General symptoms	0.099
Symptoms involving respiratory system and other chest symptoms	0.087
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.082
Disorders of lipoid metabolism	0.079
Acute respiratory infections	0.065
Organic sleep disorders	0.064
Symptoms involving urinary system	0.062
----------------------------------------
Immunosuppressive Agents	0.123
Enzyme Inhibitors	0.121
Antirheumatic Agents	0.111
Dermatologic Agents	0.100
Nucleic Acid Synthesis Inhibitors	0.085
Abortifacient Agents, Nonsteroidal	0.083
Antimetabolites, Antineoplastic	0.083
Folic Acid Antagonists	0.081
Antimalarials	0.076
Anti-Inflammatory Agents	0.072
Anti-Allergic Agents	0.065
===== phenotype 11=================================================================
proportion of pts: 0.167790559302
lambda: 11016.7776953
----------------------------------------
Hypertensive disease	0.141
Disorders of lipoid metabolism	0.127
Arthropathies and related disorders	0.113
Range name na	0.112
Rheumatism, excluding the back	0.101
Dorsopathies	0.093
Diabetes	0.081
Ischemic heart disease	0.080
Disorders of the eye and adnexa	0.076
General symptoms	0.074
----------------------------------------
Glucocorticoids	0.141
Antiemetics	0.138
Anti-Inflammatory Agents	0.127
Histamine H1 Antagonists	0.105
Anti-Allergic Agents	0.102
Vitamin B Complex	0.097
Anesthetics, Local	0.085
Antineoplastic Agents, Hormonal	0.073
Hypolipidemic Agents	0.069
Voltage-Gated Sodium Channel Blockers	0.063
===== phenotype 17=================================================================
proportion of pts: 0.140023800079
lambda: 10757.6672229
----------------------------------------
Hypertensive disease	0.094
Disorders of lipoid metabolism	0.085
Range name na	0.083
Diabetes	0.079
Nephritis, nephrotic syndrome, and nephrosis	0.078
Ischemic heart disease	0.077
Symptoms involving respiratory system and other chest symptoms	0.074
Disorders of the peripheral nervous system	0.074
Rheumatism, excluding the back	0.073
Arthropathies and related disorders	0.073
Disorders of thyroid gland	0.071
Other symptoms involving abdomen and pelvis	0.070
Operations on the musculoskeletal system	0.068
----------------------------------------
Analgesics, Opioid	0.105
Narcotics	0.097
Hypolipidemic Agents	0.091
Anticholesteremic Agents	0.091
Fibrinolytic Agents	0.088
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.084
Platelet Aggregation Inhibitors	0.083
Hypoglycemic Agents	0.079
Gastrointestinal Agents	0.075
Cathartics	0.073
Antipyretics	0.072
Anticonvulsants	0.062
===== phenotype 12=================================================================
proportion of pts: 0.146767155891
lambda: 10685.9167255
----------------------------------------
Nephritis, nephrotic syndrome, and nephrosis	0.167
Hypertensive disease	0.127
Diabetes	0.118
Disorders of the eye and adnexa	0.109
Range name na	0.106
Disorders of lipoid metabolism	0.099
Diseases of arteries, arterioles, and capillaries	0.094
Anemias	0.091
Other forms of heart disease	0.089
----------------------------------------
Vasodilator Agents	0.094
Calcium Channel Blockers	0.085
Diuretics	0.085
Anti-Arrhythmia Agents	0.084
Antihypertensive Agents	0.081
Sympatholytics	0.080
Sodium Potassium Chloride Symporter Inhibitors	0.076
Adrenergic beta-1 Receptor Antagonists	0.074
Antipyretics	0.072
Anti-Inflammatory Agents	0.068
Anti-Inflammatory Agents, Non-Steroidal	0.068
Cyclooxygenase Inhibitors	0.068
Platelet Aggregation Inhibitors	0.065
===== phenotype 23=================================================================
proportion of pts: 0.149940499802
lambda: 10451.9104277
----------------------------------------
Hypertensive disease	0.150
Disorders of lipoid metabolism	0.142
Range name na	0.118
Ischemic heart disease	0.115
Other forms of heart disease	0.111
Symptoms involving respiratory system and other chest symptoms	0.105
Diabetes	0.104
General symptoms	0.083
Rheumatism, excluding the back	0.071
----------------------------------------
Adrenergic beta-Antagonists	0.122
Adrenergic alpha-1 Receptor Antagonists	0.121
Sodium Potassium Chloride Symporter Inhibitors	0.115
Enzyme Inhibitors	0.104
Diuretics	0.084
Gout Suppressants	0.082
Antimetabolites	0.081
Tocolytic Agents	0.080
Anticoagulants	0.077
Free Radical Scavengers	0.068
Rodenticides	0.066
===== phenotype 38=================================================================
proportion of pts: 0.153907179691
lambda: 10355.3710297
----------------------------------------
Hypertensive disease	0.128
Symptoms involving respiratory system and other chest symptoms	0.108
Range name na	0.093
Disorders of lipoid metabolism	0.085
Dorsopathies	0.080
General symptoms	0.080
Other forms of heart disease	0.076
Rheumatism, excluding the back	0.075
Other diseases of respiratory system	0.073
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.071
Other diseases of the upper respiratory tract	0.069
Other diseases of urinary system	0.063
----------------------------------------
Histamine H1 Antagonists, Non-Sedating	0.114
Bronchodilator Agents	0.113
Hypnotics and Sedatives	0.109
Anti-Allergic Agents	0.107
Glucocorticoids	0.097
Anti-Inflammatory Agents	0.093
Dermatologic Agents	0.091
Sympathomimetics	0.076
Bone Density Conservation Agents	0.067
Lipoxygenase Inhibitors	0.067
Antineoplastic Agents, Hormonal	0.065
===== phenotype 4=================================================================
proportion of pts: 0.136850456168
lambda: 10100.9312119
----------------------------------------
Disorders of fluid, electrolyte, and acid-base balance	0.120
Diseases of arteries, arterioles, and capillaries	0.094
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.094
Disorders of the eye and adnexa	0.093
Other diseases of the blood	0.092
Neoplasm of uncertain behavior of other sites & tissues	0.078
Other forms of heart disease	0.078
Cerebrovascular disease	0.075
Other diseases of skin and subcutaneous tissue	0.073
Other diseases of respiratory system	0.070
Diseases of esophagus, stomach, and duodenum	0.068
Fractures	0.066
----------------------------------------
Antihypertensive Agents	0.076
Antipyretics	0.076
Cyclooxygenase Inhibitors	0.075
Anti-Inflammatory Agents, Non-Steroidal	0.073
Anticholesteremic Agents	0.073
Diuretics	0.072
Fibrinolytic Agents	0.072
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.072
Platelet Aggregation Inhibitors	0.072
Vasodilator Agents	0.071
Calcium Channel Blockers	0.070
Proton Pump Inhibitors	0.068
Anti-Ulcer Agents	0.066
Anti-Arrhythmia Agents	0.063
===== phenotype 29=================================================================
proportion of pts: 0.146767155891
lambda: 9867.14564939
----------------------------------------
Overweight, obesity and other hyperalimentation	0.135
Organic sleep disorders	0.124
Nonspecific findings on examination of blood	0.115
Gout	0.097
Diabetes	0.090
Disorders of the peripheral nervous system	0.089
Nephritis, nephrotic syndrome, and nephrosis	0.076
Diseases of esophagus, stomach, and duodenum	0.075
Infections of skin and subcutaneous tissue	0.070
Other symptoms involving abdomen and pelvis	0.066
Other diseases of digestive system	0.062
----------------------------------------
Antihypertensive Agents	0.097
Antipyretics	0.086
Vasodilator Agents	0.084
Anti-Inflammatory Agents, Non-Steroidal	0.084
Cyclooxygenase Inhibitors	0.082
Anti-Arrhythmia Agents	0.080
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.073
Anti-Ulcer Agents	0.073
Diuretics	0.072
Fibrinolytic Agents	0.070
Anticholesteremic Agents	0.069
Platelet Aggregation Inhibitors	0.068
Angiotensin-Converting Enzyme Inhibitors	0.061
===== phenotype 34=================================================================
proportion of pts: 0.141213804046
lambda: 9816.27937044
----------------------------------------
Anemias	0.134
Hypertensive disease	0.129
Diabetes	0.115
Nutritional deficiencies	0.114
Nonspecific findings on examination of blood	0.096
Range name na	0.090
Symptoms involving digestive system	0.090
Diseases of esophagus, stomach, and duodenum	0.082
General symptoms	0.078
Disorders of fluid, electrolyte, and acid-base balance	0.071
----------------------------------------
Vitamins	0.111
Proton Pump Inhibitors	0.086
Bone Density Conservation Agents	0.085
Antioxidants	0.082
Anti-Ulcer Agents	0.079
Anti-Allergic Agents	0.076
Vitamin B Complex	0.076
Antihypertensive Agents	0.075
Antipyretics	0.072
Anti-Inflammatory Agents, Non-Steroidal	0.065
Calcium Channel Blockers	0.065
Cyclooxygenase Inhibitors	0.064
Anti-Inflammatory Agents	0.064
===== phenotype 36=================================================================
proportion of pts: 0.142007140024
lambda: 9744.73867916
----------------------------------------
Chronic obstructive pulmonary disease and allied conditions	0.184
Symptoms involving respiratory system and other chest symptoms	0.130
Acute respiratory infections	0.104
Disorders of lipoid metabolism	0.104
Other diseases of the upper respiratory tract	0.099
Diseases of esophagus, stomach, and duodenum	0.085
Rheumatism, excluding the back	0.083
Range name na	0.077
Disorders of the eye and adnexa	0.072
Other diseases of skin and subcutaneous tissue	0.062
----------------------------------------
Tocolytic Agents	0.104
Bronchodilator Agents	0.100
Glucocorticoids	0.094
Anti-Bacterial Agents	0.093
Anti-Inflammatory Agents	0.088
Adrenergic beta-2 Receptor Agonists	0.084
Histamine H1 Antagonists, Non-Sedating	0.078
Anti-Allergic Agents	0.076
Vasodilator Agents	0.076
Anti-Asthmatic Agents	0.073
Anti-Ulcer Agents	0.069
Antihypertensive Agents	0.065
===== phenotype 5=================================================================
proportion of pts: 0.158270527568
lambda: 9588.23967536
----------------------------------------
Arthropathies and related disorders	0.137
Dorsopathies	0.133
Rheumatism, excluding the back	0.127
Hypertensive disease	0.118
Range name na	0.091
Disorders of the peripheral nervous system	0.086
Disorders of lipoid metabolism	0.081
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.079
Organic sleep disorders	0.075
General symptoms	0.073
----------------------------------------
Analgesics, Non-Narcotic	0.135
Calcium Channel Blockers	0.113
Vasodilator Agents	0.109
Analgesics	0.108
Anti-Arrhythmia Agents	0.104
Diuretics	0.096
Anti-Anxiety Agents	0.093
Anticonvulsants	0.085
Antihypertensive Agents	0.081
Gout Suppressants	0.076
===== phenotype 3=================================================================
proportion of pts: 0.126933756446
lambda: 9068.05557031
----------------------------------------
Range name na	0.115
Hypertensive disease	0.113
General symptoms	0.103
Rheumatism, excluding the back	0.094
Dorsopathies	0.093
Arthropathies and related disorders	0.087
Other diseases of urinary system	0.086
Disorders of the eye and adnexa	0.085
Disorders of lipoid metabolism	0.085
Symptoms involving respiratory system and other chest symptoms	0.074
Symptoms involving digestive system	0.064
----------------------------------------
Antiparkinson Agents	0.132
Excitatory Amino Acid Antagonists	0.130
Antimanic Agents	0.114
Analgesics	0.112
Anticonvulsants	0.109
Anti-Anxiety Agents	0.092
Parasympatholytics	0.082
Serotonin Uptake Inhibitors	0.078
Antidepressive Agents	0.075
Antipsychotic Agents	0.075
===== phenotype 49=================================================================
proportion of pts: 0.152320507735
lambda: 8461.29444512
----------------------------------------
Dorsopathies	0.121
Hypertensive disease	0.112
Range name na	0.096
Rheumatism, excluding the back	0.087
General symptoms	0.078
Disorders of thyroid gland	0.077
Symptoms involving respiratory system and other chest symptoms	0.076
Anemias	0.075
Disorders of fluid, electrolyte, and acid-base balance	0.073
Symptoms involving cardiovascular system	0.072
Na	0.070
Acute respiratory infections	0.064
----------------------------------------
Antidepressive Agents, Tricyclic	0.139
GABA Modulators	0.119
Anti-Anxiety Agents	0.115
Anticonvulsants	0.110
Serotonin Uptake Inhibitors	0.105
Anti-Ulcer Agents	0.093
Anti-Inflammatory Agents	0.091
Anti-Inflammatory Agents, Non-Steroidal	0.082
Antipyretics	0.076
Antihypertensive Agents	0.070
===== phenotype 45=================================================================
proportion of pts: 0.135263784213
lambda: 8453.79174914
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.116
Hypertensive disease	0.115
Disorders of lipoid metabolism	0.110
General symptoms	0.110
Symptoms involving head and neck	0.088
Symptoms involving respiratory system and other chest symptoms	0.086
Other diseases of the upper respiratory tract	0.085
Arthropathies and related disorders	0.085
Other diseases of urinary system	0.072
Other disorders of the central nervous system	0.069
Na	0.064
----------------------------------------
Proton Pump Inhibitors	0.115
Antidepressive Agents, Second-Generation	0.103
Anti-Ulcer Agents	0.095
GABA Modulators	0.093
Anti-Allergic Agents	0.088
Anti-Inflammatory Agents	0.088
Anticonvulsants	0.088
Serotonin Uptake Inhibitors	0.085
Anti-Anxiety Agents	0.084
Glucocorticoids	0.083
Bronchodilator Agents	0.079
===== phenotype 27=================================================================
proportion of pts: 0.148750495835
lambda: 8097.21377041
----------------------------------------
Range name na	0.156
Hypertensive disease	0.147
Arthropathies and related disorders	0.116
Dorsopathies	0.111
Rheumatism, excluding the back	0.109
Symptoms involving respiratory system and other chest symptoms	0.108
General symptoms	0.094
Other forms of heart disease	0.091
Pain	0.068
----------------------------------------
Analgesics, Opioid	0.149
Narcotics	0.145
Analgesics, Non-Narcotic	0.143
Anesthetics, Local	0.115
Anti-Arrhythmia Agents	0.102
Voltage-Gated Sodium Channel Blockers	0.100
Anticoagulants	0.094
Rodenticides	0.078
Antitussive Agents	0.075
===== phenotype 7=================================================================
proportion of pts: 0.130900436335
lambda: 8064.16973567
----------------------------------------
Hypertensive disease	0.172
Disorders of lipoid metabolism	0.152
Range name na	0.123
Arthropathies and related disorders	0.102
Disorders of the eye and adnexa	0.099
Diabetes	0.094
Dorsopathies	0.092
Diseases of esophagus, stomach, and duodenum	0.091
Rheumatism, excluding the back	0.076
----------------------------------------
Enzyme Inhibitors	0.142
Immunosuppressive Agents	0.141
Antirheumatic Agents	0.139
Dermatologic Agents	0.123
Antimetabolites, Antineoplastic	0.117
Nucleic Acid Synthesis Inhibitors	0.117
Abortifacient Agents, Nonsteroidal	0.114
Folic Acid Antagonists	0.106
===== phenotype 48=================================================================
proportion of pts: 0.137247124157
lambda: 8021.42615689
----------------------------------------
Dorsopathies	0.113
Rheumatism, excluding the back	0.108
Hypertensive disease	0.107
Arthropathies and related disorders	0.105
Other symptoms involving abdomen and pelvis	0.105
Symptoms involving respiratory system and other chest symptoms	0.085
Symptoms involving digestive system	0.081
Symptoms involving urinary system	0.078
Range name na	0.074
Other diseases of urinary system	0.073
Diseases of esophagus, stomach, and duodenum	0.071
----------------------------------------
Bronchodilator Agents	0.136
Proton Pump Inhibitors	0.128
Anti-Allergic Agents	0.125
Anti-Ulcer Agents	0.119
Anti-Inflammatory Agents	0.116
Dermatologic Agents	0.102
Anti-Arrhythmia Agents	0.100
Calcium Channel Blockers	0.089
Antihypertensive Agents	0.086
===== phenotype 16=================================================================
proportion of pts: 0.160650535502
lambda: 7640.72418713
----------------------------------------
Hypertensive disease	0.144
Na	0.104
Disorders of lipoid metabolism	0.103
Acute respiratory infections	0.102
Diabetes	0.098
Organic sleep disorders	0.093
Symptoms involving respiratory system and other chest symptoms	0.091
Chronic obstructive pulmonary disease and allied conditions	0.090
General symptoms	0.088
Dorsopathies	0.085
----------------------------------------
Antidepressive Agents, Second-Generation	0.134
Bronchodilator Agents	0.128
Diuretics	0.125
Serotonin Uptake Inhibitors	0.120
Calcium Channel Blockers	0.117
Dermatologic Agents	0.110
Adrenergic beta-2 Receptor Agonists	0.095
Analgesics	0.088
Antihypertensive Agents	0.083
===== phenotype 10=================================================================
proportion of pts: 0.145577151924
lambda: 7476.20455594
----------------------------------------
Other inflammatory conditions of skin and subcutaneous tissue	0.327
Other diseases of skin and subcutaneous tissue	0.180
Rheumatism, excluding the back	0.102
Symptoms involving skin and other integumentary tissue	0.097
Neoplasm of uncertain behavior of other sites & tissues	0.082
Benign neoplasm of skin	0.076
Range name na	0.075
Other diseases due to viruses and chlamydiae	0.060
----------------------------------------
Antihypertensive Agents	0.104
Anti-Inflammatory Agents, Non-Steroidal	0.090
Cyclooxygenase Inhibitors	0.088
Antipyretics	0.081
Anti-Inflammatory Agents	0.081
Anticholesteremic Agents	0.079
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.075
Platelet Aggregation Inhibitors	0.069
Fibrinolytic Agents	0.069
Anti-Arrhythmia Agents	0.068
Vasodilator Agents	0.067
Proton Pump Inhibitors	0.064
Anti-Ulcer Agents	0.064
===== phenotype 6=================================================================
proportion of pts: 0.140817136057
lambda: 7412.91981164
----------------------------------------
Other forms of heart disease	0.163
Hypertensive disease	0.152
Range name na	0.144
Disorders of the eye and adnexa	0.107
Arthropathies and related disorders	0.104
Symptoms involving skin and other integumentary tissue	0.099
Nephritis, nephrotic syndrome, and nephrosis	0.081
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.079
Chronic obstructive pulmonary disease and allied conditions	0.070
----------------------------------------
Bronchodilator Agents	0.100
Anti-Inflammatory Agents	0.091
Anticoagulants	0.090
Anti-Allergic Agents	0.090
Bone Density Conservation Agents	0.087
Enzyme Inhibitors	0.086
Diuretics	0.086
Rodenticides	0.083
Antihypertensive Agents	0.076
Anti-Arrhythmia Agents	0.075
Antineoplastic Agents, Hormonal	0.071
Anti-Asthmatic Agents	0.065
===== phenotype 20=================================================================
proportion of pts: 0.140023800079
lambda: 7338.65852211
----------------------------------------
Hypertensive disease	0.107
Range name na	0.096
Other forms of heart disease	0.083
Symptoms involving respiratory system and other chest symptoms	0.082
Diseases of esophagus, stomach, and duodenum	0.076
Anemias	0.073
Symptoms involving digestive system	0.073
Other diseases of respiratory system	0.073
Diseases of veins and lymphatics, and other diseases of circulatory system	0.072
Other diseases of intestines and peritoneum	0.069
General symptoms	0.066
Diabetes	0.066
Other symptoms involving abdomen and pelvis	0.064
----------------------------------------
Analgesics, Opioid	0.178
Narcotics	0.171
Proton Pump Inhibitors	0.150
Anti-Anxiety Agents	0.131
Antipsychotic Agents	0.126
Anti-Ulcer Agents	0.123
Anti-Infective Agents	0.121
===== phenotype 30=================================================================
proportion of pts: 0.13962713209
lambda: 6882.92206134
----------------------------------------
Hypertensive disease	0.148
Other symptoms involving abdomen and pelvis	0.104
Other diseases of intestines and peritoneum	0.103
General symptoms	0.100
Neurotic, personality, nonpsychotic disorders	0.083
Acute respiratory infections	0.082
Range name na	0.081
Disorders of lipoid metabolism	0.079
Symptoms involving urinary system	0.079
Other diseases of urinary system	0.073
Diseases of esophagus, stomach, and duodenum	0.069
----------------------------------------
Hypnotics and Sedatives	0.118
Anti-Inflammatory Agents, Non-Steroidal	0.117
Cyclooxygenase Inhibitors	0.117
Platelet Aggregation Inhibitors	0.116
Antipyretics	0.114
Fibrinolytic Agents	0.112
Antioxidants	0.109
Antihypertensive Agents	0.099
Vasodilator Agents	0.098
===== phenotype 44=================================================================
proportion of pts: 0.146767155891
lambda: 6684.96955414
----------------------------------------
Hypertensive disease	0.147
Other forms of heart disease	0.129
Ischemic heart disease	0.110
Disorders of lipoid metabolism	0.108
General symptoms	0.106
Symptoms involving respiratory system and other chest symptoms	0.100
Range name na	0.091
Other diseases of skin and subcutaneous tissue	0.074
Diabetes	0.071
Na	0.064
----------------------------------------
Immunosuppressive Agents	0.151
Sympatholytics	0.127
Adrenergic beta-1 Receptor Antagonists	0.117
Antirheumatic Agents	0.115
Anti-Arrhythmia Agents	0.113
Angiotensin-Converting Enzyme Inhibitors	0.103
Hypolipidemic Agents	0.098
Antimetabolites, Antineoplastic	0.092
Folic Acid Antagonists	0.084
===== phenotype 8=================================================================
proportion of pts: 0.142800476002
lambda: 6233.97500997
----------------------------------------
Hypertensive disease	0.169
Range name na	0.125
Disorders of lipoid metabolism	0.115
Diabetes	0.101
Symptoms involving respiratory system and other chest symptoms	0.100
Other forms of heart disease	0.096
General symptoms	0.082
Ischemic heart disease	0.081
Rheumatism, excluding the back	0.066
Disorders of the eye and adnexa	0.065
----------------------------------------
Tubulin Modulators	0.150
Antineoplastic Agents, Phytogenic	0.127
Anti-Infective Agents, Local	0.119
Phosphodiesterase Inhibitors	0.106
Central Nervous System Stimulants	0.105
Hypoglycemic Agents	0.104
Analgesics	0.102
Purinergic P1 Receptor Antagonists	0.097
Adrenergic beta-2 Receptor Agonists	0.090
===== phenotype 18=================================================================
proportion of pts: 0.130900436335
lambda: 6207.39287033
----------------------------------------
Hypertensive disease	0.122
Range name na	0.121
Arthropathies and related disorders	0.099
Rheumatism, excluding the back	0.096
Nonspecific findings on examination of blood	0.095
Organic sleep disorders	0.089
Other diseases of skin and subcutaneous tissue	0.084
Neurotic, personality, nonpsychotic disorders	0.082
Na	0.081
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.066
Certain traumatic complications and unspecified injuries	0.064
----------------------------------------
Serotonin Uptake Inhibitors	0.160
Hypnotics and Sedatives	0.142
Anti-Anxiety Agents	0.134
GABA Modulators	0.128
Antidepressive Agents, Second-Generation	0.128
Anticonvulsants	0.109
Antidepressive Agents	0.106
Antihypertensive Agents	0.093
===== phenotype 37=================================================================
proportion of pts: 0.131693772313
lambda: 5509.19792591
----------------------------------------
Hypertensive disease	0.102
Symptoms involving respiratory system and other chest symptoms	0.100
General symptoms	0.091
Other diseases of respiratory system	0.090
Range name na	0.089
Diseases of other endocrine glands	0.080
Acute respiratory infections	0.080
Pneumonia and influenza	0.080
Other forms of heart disease	0.079
Arthropathies and related disorders	0.073
Certain traumatic complications and unspecified injuries	0.069
Ischemic heart disease	0.067
----------------------------------------
Calcium Channel Blockers	0.170
Vasodilator Agents	0.162
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.152
Anticholesteremic Agents	0.149
Diuretics	0.141
Antihypertensive Agents	0.130
Antineoplastic Agents	0.095
===== phenotype 22=================================================================
proportion of pts: 0.122570408568
lambda: 5141.4938012
----------------------------------------
Drug dependence	0.135
Other diseases of the upper respiratory tract	0.114
Na	0.113
Neurotic, personality, nonpsychotic disorders	0.112
Hypertensive disease	0.108
Chronic obstructive pulmonary disease and allied conditions	0.108
Pneumonia and influenza	0.081
Diseases of the ear and mastoid process	0.079
Symptoms involving respiratory system and other chest symptoms	0.078
Symptoms involving urinary system	0.071
----------------------------------------
Cyclooxygenase Inhibitors	0.122
Serotonin Uptake Inhibitors	0.121
Antipyretics	0.121
Anti-Inflammatory Agents, Non-Steroidal	0.121
Anti-Allergic Agents	0.114
Antihypertensive Agents	0.107
Antidepressive Agents, Second-Generation	0.104
Bronchodilator Agents	0.096
Anti-Ulcer Agents	0.094
===== phenotype 31=================================================================
proportion of pts: 0.135263784213
lambda: 4223.00792737
----------------------------------------
Diabetes	0.195
Hypertensive disease	0.143
Disorders of lipoid metabolism	0.133
Dorsopathies	0.112
Rheumatism, excluding the back	0.101
Symptoms involving head and neck	0.095
Neurotic, personality, nonpsychotic disorders	0.087
Na	0.067
Hereditary and degenerative diseases of the central nervous system	0.066
----------------------------------------
Hypoglycemic Agents	0.172
Calcium Channel Blockers	0.165
Analgesics	0.157
Anticonvulsants	0.135
Antimanic Agents	0.133
Serotonin Uptake Inhibitors	0.130
Antihypertensive Agents	0.108
===== phenotype 39=================================================================
proportion of pts: 0.130107100357
lambda: 4209.77656273
----------------------------------------
Other forms of heart disease	0.114
Other diseases of respiratory system	0.105
General symptoms	0.099
Symptoms involving respiratory system and other chest symptoms	0.094
Range name na	0.081
Complications of surgical and medical care, not elsewhere classified	0.080
Other diseases of intestines and peritoneum	0.077
Anemias	0.076
Hereditary and degenerative diseases of the central nervous system	0.073
Other diseases of urinary system	0.070
Ill-defined and unknown causes of morbidity and mortality	0.068
Neurotic, personality, nonpsychotic disorders	0.063
----------------------------------------
Antipyretics	0.179
Anti-Ulcer Agents	0.178
GABA Modulators	0.173
Antihypertensive Agents	0.166
Enzyme Inhibitors	0.163
Fibrinolytic Agents	0.142
===== phenotype 43=================================================================
proportion of pts: 0.119000396668
lambda: 3382.38454275
----------------------------------------
Hypertensive disease	0.151
Disorders of lipoid metabolism	0.116
Other diseases of urinary system	0.110
Range name na	0.104
Diabetes	0.102
Symptoms involving urinary system	0.099
Mycoses	0.086
Arthropathies and related disorders	0.084
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.077
Disorders of the eye and adnexa	0.072
----------------------------------------
Antifungal Agents	0.281
Anti-Bacterial Agents	0.278
Anti-Ulcer Agents	0.214
Antihypertensive Agents	0.119
Ionophores	0.108
===== phenotype 47=================================================================
proportion of pts: 0.109877032923
lambda: 2876.86847143
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.199
Operations on the musculoskeletal system	0.184
Operations on the cardiovascular system	0.122
Ischemic heart disease	0.094
Other diseases of respiratory system	0.090
Diseases of veins and lymphatics, and other diseases of circulatory system	0.087
Operations on the nose, mouth, and pharynx	0.082
Diseases of arteries, arterioles, and capillaries	0.079
Diseases of oral cavity, salivary glands, and jaws	0.064
----------------------------------------
Antihypertensive Agents	0.242
Antipyretics	0.221
Anti-Ulcer Agents	0.197
Anti-Inflammatory Agents, Non-Steroidal	0.175
Anti-Arrhythmia Agents	0.165
===== phenotype 46=================================================================
proportion of pts: 0.101943673146
lambda: 2318.89186732
----------------------------------------
Other disorders of the central nervous system	0.143
Disorders of fluid, electrolyte, and acid-base balance	0.126
Na	0.121
General symptoms	0.117
Congenital anomalies	0.100
Symptoms involving nervous and musculoskeletal systems	0.092
Other diseases of respiratory system	0.082
Rheumatism, excluding the back	0.082
Cerebrovascular disease	0.070
Symptoms involving urinary system	0.068
----------------------------------------
Platelet Aggregation Inhibitors	0.266
Fibrinolytic Agents	0.251
Antipyretics	0.250
Antihypertensive Agents	0.233
===== phenotype 21=================================================================
proportion of pts: 0.103530345101
lambda: 1558.81351245
----------------------------------------
Other forms of heart disease	0.134
Hypertensive disease	0.124
Other diseases of respiratory system	0.118
Symptoms involving respiratory system and other chest symptoms	0.114
Range name na	0.114
Disorders of fluid, electrolyte, and acid-base balance	0.111
Nephritis, nephrotic syndrome, and nephrosis	0.105
Other diseases of urinary system	0.092
Miscellaneous diagnostic and therapeutic procedures	0.088
----------------------------------------
Anti-Bacterial Agents	0.644
Anti-Anxiety Agents	0.356
